Skip to content
10-Q

Quarterly Report

PALISADE BIO, INC. PALI

0001193125-25-274262

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 149M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 5.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.5M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.17M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$7.7M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$9.81M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $5.23M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $9.82M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $8.04M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.21M
Stockholders Equity Q3 2025 · Jun 30, 2025 $2.62M
Stockholders Equity Q3 2025 · Dec 31, 2024 $7.49M
Stockholders Equity Q3 2025 · Sep 30, 2024 $6.61M
Stockholders Equity Q3 2025 · Jun 30, 2024 $9.95M
Stockholders Equity Q3 2025 · Dec 31, 2023 $11.31M
Current Liabilities Q3 2025 · Sep 30, 2025 $3.48M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.24M
Total Liabilities Q3 2025 · Sep 30, 2025 $3.76M
Total Liabilities Q3 2025 · Dec 31, 2024 $3.39M
Current Assets Q3 2025 · Sep 30, 2025 $6.83M
Current Assets Q3 2025 · Dec 31, 2024 $10.49M
Total Assets Q3 2025 · Sep 30, 2025 $6.97M
Total Assets Q3 2025 · Dec 31, 2024 $10.88M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$9.50
Eps Basic Q3 2025 · Sep 30, 2025 −$0.38
Eps Basic Q3 2025 · Sep 30, 2025 −$1.38
Eps Basic Q3 2025 · Sep 30, 2024 −$2.32
Eps Basic Q3 2025 · Sep 30, 2024 −$9.50
Net Income Q3 2025 · Sep 30, 2025 −$2.87M
Net Income Q3 2025 · Sep 30, 2025 −$7.88M
Net Income Q3 2025 · Sep 30, 2024 −$3.49M
Net Income Q3 2025 · Sep 30, 2024 −$11.09M
Operating Income Q3 2025 · Sep 30, 2025 −$2.92M
Operating Income Q3 2025 · Sep 30, 2025 −$8.08M
Operating Income Q3 2025 · Sep 30, 2024 −$3.59M
Operating Income Q3 2025 · Sep 30, 2024 −$11.48M
Rd Expense Q3 2025 · Sep 30, 2024 $16M
Rd Expense Q3 2025 · Sep 30, 2024 $16M